NEW YORK (GenomeWeb News) – McKinley Scientific and New Objective today announced a co-marketing and development deal for the expansion of applications for liquid chromatography-mass spectrometry systems.

Sparta, NJ-based McKinley will provide financing and support services for mass spectrometry, while Woburn, Mass.-based New Objective is providing its nanospray front end technologies. Together, the firms will co-market their products and develop distribution and services to deliver mass spec solutions, they said.

Further financial and other details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.